Complications of diagnostic cardiac catheterisation: results from a confidential inquiry into cardiac catheter complications. Heart. 2006;92:810 4. 33. Levine GN, Kern MJ, Berger PB, et al. Management of patients under- going percutaneous coronary revascularization. Ann Intern Med. 2003;139:123 36. 34. Ko DT, Wang Y, Alter DA, et al. Regional variation in cardiac catheteriza- tion appropriateness and baseline risk after acute myocardial infarction. J Am Coll Cardiol. 2008;51:716 23. 35. Douglas PS, Patel MR, Bailey SR, et al. Hospital variability in the rate of finding obstructive coronary artery disease at elective, diagnostic coronary angiography. J Am Coll Cardiol. 2011;58:801 9. 36. Patel MR, Peterson ED, Dai D, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010;362:886 95 37. Bradley SM, Maddox TM, Stanislawski MA, et al. Normal coronary rates for elective angiography in the Veterans Affairs Healthcare System: insights from theVA CART Program (VeteransAffairs ClinicalAssessment Reporting and Tracking). J Am Coll Cardiol. 2014;63:417 26. 38. Guldager B, Jelnes R, J rgensen SJ, et al. EDTA treatment of intermit- tent claudication a double-blind, placebo-controlled study. J Intern Med. 1992;231:261 7. 39. van Rij AM, Solomon C, Packer SG, et al. Chelation therapy for inter- mittent claudication. A double-blind, randomized, controlled trial. Circulation. 1994;90:1194 9. 40. Sloth-Nielsen J, Guldager B, Mouritzen C, et al. Arteriographic findings in EDTA chelation therapy on peripheral arteriosclerosis. Am J Surg. 1991;162:122 5. 41. Knudtson ML, Wyse DG, Galbraith PD, et al. Chelation therapy for isch- emic heart disease: a randomized controlled trial. JAMA. 2002;287:481 6. 42. Lamas GA, Goertz C, Boineau R, et al. Effect of disodium EDTA chela- tion regimen on cardiovascular events in patients with previous myocar- dial infarction: the TACT randomized trial. JAMA. 2013;309:1241 50. 43. Tellez-Plaza M, Guallar E, Howard BV, et al. 